Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Forensic Science International

• Publication date

  2008-05-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.FORSCIINT.2007.11.001PMID 18155375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term stability of various drugs and metabolites in urine, and preventive measures against their decomposition with special attention to filtration sterilization.

  2008cited by this paper
• メタンフェタミン摂取者尿中の p-ヒドロキシメタンフェタミン抱合体濃度およびその加水分解条件の検討

  2007cited by this paper
• Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine.

  2006cited by this paper
• Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats

  2006cited by this paper
• Metabolism of designer drugs of abuse.

  2005cited by this paper
• Drugs and poisons in humans : a handbook of practical analysis

  2005cited by this paper
• Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine.

  2004cited by this paper
• Mechanisms underlying postmortem redistribution of drugs: a review.

  2003cited by this paper
• A fatal paramethoxymethamphetamine intoxication.

  2003cited by this paper
• Three fatal cases of PMA and PMMA poisoning in Denmark.

  2003cited by this paper
• Determination of methamphetamine and its metabolites incorporated in hair by column-switching liquid chromatography-mass spectrometry.

  2003cited by this paper
• Paramethoxyamphetamine (PMA) poisoning; a ‘party drug’ with lethal effects

  2003cited by this paper
• Caveat Emptor: Death involving the use of 4-methoxyamphetamine.

  2002cited by this paper
• Three cases of fatal paramethoxyamphetamine overdose.

  2001cited by this paper
• Column-switching high-performance liquid chromatography-electrospray ionization mass spectrometry for identification of heroin metabolites in human urine.

  2001cited by this paper
• Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

  2001cited by this paper
• Poisoning with the recreational drug paramethoxyamphetamine (“death”)

  2001cited by this paper
• Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results.

  2000cited by this paper
• Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives.

  1999cited by this paper
• METHAMPHETAMINE : A STUDY OF POSTMORTEM REDISTRIBUTION

  1999cited by this paper
• Recent paramethoxyamphetamine deaths

  1998cited by this paper
• Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?

  1998cited by this paper
• Recent paramethoxyamphetamine deaths.

  1998cited by this paper
• Case History 3

  1997cited by this paper
• PIHKAL: A Chemical Love Story

  1991cited by this paper
• Liquid chromatographic and mass spectral analysis of N-substituted analogues of 3,4-methylenedioxyamphetamine.

  1988cited by this paper
• Introduction to Drug Metabolism

  1986cited by this paper
• Disposition of toxic drugs and chemicals in man

  1982cited by this paper
• Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine.

  1979cited by this paper
• Cyanohydridoborate anion as a selective reducing agent

  1971cited by this paper
• Interpretation of Mass Spectra

  1966cited by this paper

• A review of the advances in insect evidence analysis for estimating postmortem interval and detecting drug toxicity.

  2025cites this paper
• The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature

  2024cites this paper
• Analytical techniques for the detection of novel psychoactive substances and their metabolites

  2022cites this paper
• Simultaneous Quantitation of Seven Phenethylamine-Type Drugs in Forensic Blood and Urine Samples by UHPLC-MS/MS.

  2021cites this paper
• Development of surface-enhanced Raman spectroscopy application for determination of illicit drugs: Towards a practical sensor.

  2019cites this paper
• Metabolism of Synthetic Cathinones

  2018cites this paper
• The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  2017cites this paper
• A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylamines.

  2017cites this paper
• Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS.

  2016cites this paper
• The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines

  2016cites this paper
• Application of metabolomics to toxicology of drugs of abuse: A mini review of metabolomics approach to acute and chronic toxicity studies.

  2016cites this paper
• Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS.

  2015cites this paper
• High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS

  2015cites this paper
• Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

  2014cites this paper
• Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays

  2014cites this paper
• „Legal highs“

  2014cites this paper
• Comparative in Vitro Studies of the Metabolism of Six 4-Substituted Methamphetamines and Their Inhibition of Cytochrome P450 2D6 by GC-MS with Trifluoroacetyl Derivatization

  2013cites this paper
• Comprehensive forensic toxicological analysis of designer drugs

  2013cites this paper
• Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC–EI–MS–MS

  2013cites this paper
• Cross-reactivity studies and predictive modeling of “Bath Salts” and other amphetamine-type stimulants with amphetamine screening immunoassays

  2013cites this paper
• Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism

  2013cites this paper
• The trend of drug abuse in Taiwan during the years 1999 to 2011

  2013cites this paper
• Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement.

  2012cites this paper
• When Toxicology Report Is Negative in a Suspected Overdosed Patient: The World of Designer Drugs

  2012cites this paper
• Psychoactive Phenethylamine, Piperazine, and Pyrrolidinophenone Derivatives

  2012cites this paper
• "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.

  2012cites this paper
• Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review

  2011cites this paper
• Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis

  2011cites this paper
• Simultaneous separation and confirmation of amphetamine and related drugs in equine plasma by non-aqueous capillary-electrophoresis-tandem mass spectrometry.

  2010cites this paper
• Bioanalysis of new designer drugs.

  2010cites this paper
• A technique combining trifluoroacetyl derivatization and gas chromatography-mass spectrometry to distinguish methamphetamine and its 4-substituted analogs.

  2010cites this paper
• Analytical Toxicology of Emerging Drugs of Abuse

  2010cites this paper
• Simultaneous analysis of six novel hallucinogenic (tetrahydrobenzodifuranyl)aminoalkanes (FLYs) and (benzodifuranyl)aminoalkanes (DragonFLYs) by GC-MS, LC-MS, and LC-MS-MS

  2009cites this paper
• Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.

  2009cites this paper
• Direct Analysis of Conjugate Metabolites of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and Their Designer Drugs in Biological Fluids

  2009cites this paper
• Forensic science.

  2009cites this paper
• The analytical profile of some 4-methylthioamphetamine (4-MTA) homologues.

  2009cites this paper
• Discrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamines by gas chromatography-mass spectrometry

  2008cites this paper